

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.39260497 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.31882444 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.23493128 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.11916271 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.89739058 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.57047574 |
| 7 | tachykinin receptor signaling pathway (GO:0007217) | 4.48281143 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.46939182 |
| 9 | glutamate secretion (GO:0014047) | 4.42637615 |
| 10 | vocalization behavior (GO:0071625) | 4.39092580 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.26053219 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.24201879 |
| 13 | dendritic spine morphogenesis (GO:0060997) | 4.19183453 |
| 14 | serotonin metabolic process (GO:0042428) | 4.13241735 |
| 15 | regulation of hippo signaling (GO:0035330) | 4.09533316 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.06825946 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.01877109 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 3.95146601 |
| 19 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.94773470 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 3.91651820 |
| 21 | protein localization to synapse (GO:0035418) | 3.91122354 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 3.90714991 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.88654151 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.88381085 |
| 25 | behavioral response to nicotine (GO:0035095) | 3.84062201 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.82667238 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 3.80426202 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 3.77808619 |
| 29 | exploration behavior (GO:0035640) | 3.77408976 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.77090455 |
| 31 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.70560787 |
| 32 | primary amino compound metabolic process (GO:1901160) | 3.66463155 |
| 33 | synaptic transmission, glutamatergic (GO:0035249) | 3.64867637 |
| 34 | sodium ion export (GO:0071436) | 3.63259980 |
| 35 | negative regulation of protein localization to cell surface (GO:2000009) | 3.58136404 |
| 36 | auditory behavior (GO:0031223) | 3.56310713 |
| 37 | activation of protein kinase A activity (GO:0034199) | 3.52030792 |
| 38 | innervation (GO:0060384) | 3.51262800 |
| 39 | long-term memory (GO:0007616) | 3.51145783 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.49877079 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.49235484 |
| 42 | proline transport (GO:0015824) | 3.48061605 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47794606 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.44543217 |
| 45 | histone H2A acetylation (GO:0043968) | 3.42675515 |
| 46 | indole-containing compound metabolic process (GO:0042430) | 3.42476329 |
| 47 | glutamate receptor signaling pathway (GO:0007215) | 3.39714120 |
| 48 | neuronal action potential (GO:0019228) | 3.35023718 |
| 49 | response to auditory stimulus (GO:0010996) | 3.33316087 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33291367 |
| 51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.31147770 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.30632153 |
| 53 | central nervous system myelination (GO:0022010) | 3.30160286 |
| 54 | axon ensheathment in central nervous system (GO:0032291) | 3.30160286 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26917707 |
| 56 | axonal fasciculation (GO:0007413) | 3.26646199 |
| 57 | dendrite morphogenesis (GO:0048813) | 3.26633568 |
| 58 | cell communication by electrical coupling (GO:0010644) | 3.26469465 |
| 59 | detection of light stimulus involved in visual perception (GO:0050908) | 3.26400996 |
| 60 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.26400996 |
| 61 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21912656 |
| 62 | peristalsis (GO:0030432) | 3.21429613 |
| 63 | neuronal ion channel clustering (GO:0045161) | 3.20433048 |
| 64 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.18353948 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.17158412 |
| 66 | interkinetic nuclear migration (GO:0022027) | 3.17116488 |
| 67 | reflex (GO:0060004) | 3.17000268 |
| 68 | neurotransmitter transport (GO:0006836) | 3.16304122 |
| 69 | neuron recognition (GO:0008038) | 3.15335716 |
| 70 | regulation of ARF protein signal transduction (GO:0032012) | 3.14721836 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.14178187 |
| 72 | righting reflex (GO:0060013) | 3.13622882 |
| 73 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.12999520 |
| 74 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10926694 |
| 75 | regulation of postsynaptic membrane potential (GO:0060078) | 3.10123332 |
| 76 | long-term synaptic potentiation (GO:0060291) | 3.09627080 |
| 77 | protein K48-linked deubiquitination (GO:0071108) | 3.08013077 |
| 78 | transmission of nerve impulse (GO:0019226) | 3.07443586 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 3.06714229 |
| 80 | neuromuscular process controlling balance (GO:0050885) | 3.05949381 |
| 81 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05717063 |
| 82 | regulation of neurotransmitter uptake (GO:0051580) | 3.02769395 |
| 83 | startle response (GO:0001964) | 3.01890836 |
| 84 | prepulse inhibition (GO:0060134) | 2.99823360 |
| 85 | synaptic vesicle endocytosis (GO:0048488) | 2.97353424 |
| 86 | membrane depolarization during action potential (GO:0086010) | 2.97080618 |
| 87 | dendritic spine organization (GO:0097061) | 2.96027900 |
| 88 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.95798040 |
| 89 | regulation of vesicle fusion (GO:0031338) | 2.95618565 |
| 90 | chemosensory behavior (GO:0007635) | 2.94067336 |
| 91 | opioid receptor signaling pathway (GO:0038003) | 2.92922118 |
| 92 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.92778116 |
| 93 | auditory receptor cell stereocilium organization (GO:0060088) | 2.92492547 |
| 94 | mechanosensory behavior (GO:0007638) | 2.92037389 |
| 95 | cerebellar Purkinje cell layer development (GO:0021680) | 2.90807008 |
| 96 | regulation of neurotransmitter secretion (GO:0046928) | 2.89339113 |
| 97 | potassium ion import (GO:0010107) | 2.89031026 |
| 98 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.88964815 |
| 99 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.88684813 |
| 100 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.86818893 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.86813062 |
| 102 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.85916834 |
| 103 | glycine transport (GO:0015816) | 2.85692989 |
| 104 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.85632608 |
| 105 | regulation of neurotransmitter levels (GO:0001505) | 2.84800981 |
| 106 | regulation of pigment cell differentiation (GO:0050932) | 2.83529652 |
| 107 | cellular potassium ion transport (GO:0071804) | 2.82220522 |
| 108 | potassium ion transmembrane transport (GO:0071805) | 2.82220522 |
| 109 | synapse assembly (GO:0007416) | 2.81704109 |
| 110 | neuromuscular process controlling posture (GO:0050884) | 2.81053858 |
| 111 | regulation of skeletal muscle contraction (GO:0014819) | 2.80576530 |
| 112 | phasic smooth muscle contraction (GO:0014821) | 2.79259233 |
| 113 | potassium ion homeostasis (GO:0055075) | 2.78128831 |
| 114 | synapse organization (GO:0050808) | 2.77637540 |
| 115 | postsynaptic membrane organization (GO:0001941) | 2.76949835 |
| 116 | membrane hyperpolarization (GO:0060081) | 2.75616560 |
| 117 | establishment of nucleus localization (GO:0040023) | 2.75355261 |
| 118 | presynaptic membrane assembly (GO:0097105) | 2.75243401 |
| 119 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.75137656 |
| 120 | membrane depolarization (GO:0051899) | 2.74029631 |
| 121 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.73846947 |
| 122 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.73515096 |
| 123 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.73413984 |
| 124 | behavioral response to ethanol (GO:0048149) | 2.72819967 |
| 125 | vesicle transport along microtubule (GO:0047496) | 2.72623958 |
| 126 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.71408137 |
| 127 | regulation of neurotransmitter transport (GO:0051588) | 2.69930973 |
| 128 | positive regulation of synapse maturation (GO:0090129) | 2.68187126 |
| 129 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.67116444 |
| 130 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66123839 |
| 131 | cerebellar granule cell differentiation (GO:0021707) | 2.66086333 |
| 132 | learning (GO:0007612) | 2.65990270 |
| 133 | positive regulation of developmental pigmentation (GO:0048087) | 2.65647041 |
| 134 | urate metabolic process (GO:0046415) | 2.65375338 |
| 135 | positive regulation of dendritic spine development (GO:0060999) | 2.64716195 |
| 136 | detection of calcium ion (GO:0005513) | 2.64048503 |
| 137 | positive regulation of synaptic transmission (GO:0050806) | 2.63116919 |
| 138 | positive regulation of potassium ion transport (GO:0043268) | 2.61211188 |
| 139 | intraspecies interaction between organisms (GO:0051703) | 2.61092255 |
| 140 | snRNA transcription (GO:0009301) | 2.59111646 |
| 141 | cellular ketone body metabolic process (GO:0046950) | 2.58829787 |
| 142 | alanine transport (GO:0032328) | 2.58793751 |
| 143 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.57551540 |
| 144 | potassium ion transport (GO:0006813) | 2.57297845 |
| 145 | negative regulation of neurotransmitter transport (GO:0051589) | 2.57187513 |
| 146 | photoreceptor cell maintenance (GO:0045494) | 2.54892643 |
| 147 | multicellular organismal movement (GO:0050879) | 2.52164191 |
| 148 | musculoskeletal movement (GO:0050881) | 2.52164191 |
| 149 | dermatan sulfate biosynthetic process (GO:0030208) | 2.51778150 |
| 150 | presynaptic membrane organization (GO:0097090) | 2.51051138 |
| 151 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.50823407 |
| 152 | meiotic chromosome segregation (GO:0045132) | 2.49710454 |
| 153 | histone H4-K12 acetylation (GO:0043983) | 2.49314126 |
| 154 | phosphate ion transport (GO:0006817) | 2.48802723 |
| 155 | inner ear receptor stereocilium organization (GO:0060122) | 2.46329448 |
| 156 | positive regulation of meiosis (GO:0045836) | 2.44685810 |
| 157 | gonadal mesoderm development (GO:0007506) | 2.44164041 |
| 158 | DNA methylation involved in gamete generation (GO:0043046) | 2.42635246 |
| 159 | ketone body metabolic process (GO:1902224) | 2.39816028 |
| 160 | behavioral response to cocaine (GO:0048148) | 2.39134202 |
| 161 | regulation of respiratory system process (GO:0044065) | 2.39085024 |
| 162 | positive regulation of action potential (GO:0045760) | 2.38111071 |
| 163 | rhodopsin mediated signaling pathway (GO:0016056) | 2.37706203 |
| 164 | cAMP catabolic process (GO:0006198) | 2.36835894 |
| 165 | positive regulation of fatty acid oxidation (GO:0046321) | 2.36531561 |
| 166 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.36108096 |
| 167 | endosome to pigment granule transport (GO:0043485) | 2.35898461 |
| 168 | endosome to melanosome transport (GO:0035646) | 2.35898461 |
| 169 | phospholipid translocation (GO:0045332) | 2.35307908 |
| 170 | lipid translocation (GO:0034204) | 2.35307908 |
| 171 | protein K63-linked deubiquitination (GO:0070536) | 2.34769053 |
| 172 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.33297290 |
| 173 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.33297290 |
| 174 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.32338336 |
| 175 | appendage development (GO:0048736) | 2.32320386 |
| 176 | limb development (GO:0060173) | 2.32320386 |
| 177 | indolalkylamine metabolic process (GO:0006586) | 2.30678848 |
| 178 | nonmotile primary cilium assembly (GO:0035058) | 2.30387775 |
| 179 | central nervous system neuron axonogenesis (GO:0021955) | 2.30226651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.07995054 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38975583 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91561756 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90380755 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.79710757 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74073712 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64066646 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.51511752 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51194426 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51104382 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51104382 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46504902 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46366393 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43381775 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40926696 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33889492 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.29373265 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28883469 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28515716 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28084836 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10667350 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10512964 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09852621 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.09564106 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05679530 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.05165038 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95588489 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90172962 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89825902 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85781435 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85509100 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82058845 |
| 33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81928778 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75159029 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74839878 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68787622 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64056629 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.61237449 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52255964 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52179561 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48449496 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47738345 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47605203 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46725753 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44546239 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39063462 |
| 47 | AR_19668381_ChIP-Seq_PC3_Human | 1.37904448 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37363678 |
| 49 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36166254 |
| 50 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36098371 |
| 51 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35199569 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35199569 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34299893 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33959760 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33127623 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32504572 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31724727 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31664189 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31625500 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31313086 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29499156 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28565646 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28406849 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27369302 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25830993 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24088204 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24006220 |
| 68 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.22336654 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22234269 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.21321022 |
| 71 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20341343 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20201250 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20166188 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20110624 |
| 75 | KDM2B_26808549_Chip-Seq_REH_Human | 1.20007172 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19151785 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18874118 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18348258 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17916758 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17896803 |
| 81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17896803 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17325443 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14068460 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13654127 |
| 85 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13179932 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12776518 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11821424 |
| 88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11629037 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10502486 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10331976 |
| 91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09799722 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09500755 |
| 93 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09483306 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09401427 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09195850 |
| 96 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08313559 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07786252 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07466717 |
| 99 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07255835 |
| 100 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07111616 |
| 101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06196012 |
| 102 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05769011 |
| 103 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05156905 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04872359 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04571834 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04563451 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02299364 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01681166 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01650398 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01401407 |
| 111 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.00735630 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00692155 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00149048 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99944052 |
| 115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99909196 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99692689 |
| 117 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99657455 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99154935 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99104004 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98336326 |
| 121 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97627347 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97554856 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97053064 |
| 124 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96921754 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96011062 |
| 126 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95529536 |
| 127 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94932276 |
| 128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93952430 |
| 129 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92654890 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91549895 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88697978 |
| 132 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88677415 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85556729 |
| 134 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.82713532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.07704937 |
| 2 | MP0003136_yellow_coat_color | 4.12166445 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.85186949 |
| 4 | MP0003880_abnormal_central_pattern | 3.60199667 |
| 5 | MP0004270_analgesia | 3.56728668 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.99386590 |
| 7 | MP0009745_abnormal_behavioral_response | 2.97109544 |
| 8 | MP0002064_seizures | 2.83586717 |
| 9 | MP0009046_muscle_twitch | 2.67736058 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.60979218 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.51239360 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.48152681 |
| 13 | MP0002822_catalepsy | 2.46239159 |
| 14 | MP0001486_abnormal_startle_reflex | 2.42307276 |
| 15 | MP0005171_absent_coat_pigmentation | 2.38625665 |
| 16 | MP0002272_abnormal_nervous_system | 2.36163292 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.34334324 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.32078118 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.28558224 |
| 20 | MP0004147_increased_porphyrin_level | 2.15052858 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.01853368 |
| 22 | MP0008569_lethality_at_weaning | 2.00879542 |
| 23 | MP0003646_muscle_fatigue | 1.94970238 |
| 24 | MP0003195_calcinosis | 1.91741658 |
| 25 | MP0000427_abnormal_hair_cycle | 1.88576500 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.79996558 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.78270826 |
| 28 | MP0000778_abnormal_nervous_system | 1.76570182 |
| 29 | MP0003329_amyloid_beta_deposits | 1.75956452 |
| 30 | MP0003283_abnormal_digestive_organ | 1.71659232 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.68690879 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.68181645 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.67912598 |
| 34 | MP0000955_abnormal_spinal_cord | 1.67825935 |
| 35 | MP0004924_abnormal_behavior | 1.65763399 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.65763399 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.63739603 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.62668236 |
| 39 | MP0004885_abnormal_endolymph | 1.61620213 |
| 40 | MP0002184_abnormal_innervation | 1.61195555 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.59565107 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.59506471 |
| 43 | MP0001970_abnormal_pain_threshold | 1.57219105 |
| 44 | MP0000383_abnormal_hair_follicle | 1.56912779 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.55762114 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.53117510 |
| 47 | MP0002736_abnormal_nociception_after | 1.51839307 |
| 48 | MP0004858_abnormal_nervous_system | 1.51821325 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.46356673 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.45403787 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.44877470 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.43102100 |
| 53 | MP0003122_maternal_imprinting | 1.41408811 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.40973570 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.40686114 |
| 56 | MP0003633_abnormal_nervous_system | 1.40392486 |
| 57 | MP0003787_abnormal_imprinting | 1.35558534 |
| 58 | MP0004043_abnormal_pH_regulation | 1.34460794 |
| 59 | MP0001984_abnormal_olfaction | 1.33771896 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.32311313 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.31915748 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.31473832 |
| 63 | MP0002928_abnormal_bile_duct | 1.29211126 |
| 64 | MP0001299_abnormal_eye_distance/ | 1.24365591 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.23617504 |
| 66 | MP0003634_abnormal_glial_cell | 1.21338403 |
| 67 | MP0003878_abnormal_ear_physiology | 1.19391552 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.19391552 |
| 69 | MP0003879_abnormal_hair_cell | 1.18252343 |
| 70 | MP0002160_abnormal_reproductive_system | 1.17613875 |
| 71 | MP0002229_neurodegeneration | 1.17242129 |
| 72 | MP0002168_other_aberrant_phenotype | 1.15904478 |
| 73 | MP0004233_abnormal_muscle_weight | 1.15463957 |
| 74 | MP0003690_abnormal_glial_cell | 1.14981905 |
| 75 | MP0001529_abnormal_vocalization | 1.14711486 |
| 76 | MP0002653_abnormal_ependyma_morphology | 1.14613202 |
| 77 | MP0004142_abnormal_muscle_tone | 1.14569513 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 1.12337453 |
| 79 | MP0004215_abnormal_myocardial_fiber | 1.11448018 |
| 80 | MP0004133_heterotaxia | 1.11294809 |
| 81 | MP0002152_abnormal_brain_morphology | 1.10650785 |
| 82 | MP0000751_myopathy | 1.10499548 |
| 83 | MP0003631_nervous_system_phenotype | 1.08965561 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.08781950 |
| 85 | MP0010386_abnormal_urinary_bladder | 1.08367247 |
| 86 | MP0000920_abnormal_myelination | 1.06086614 |
| 87 | MP0003172_abnormal_lysosome_physiology | 1.06074254 |
| 88 | MP0003137_abnormal_impulse_conducting | 1.05728964 |
| 89 | MP0002090_abnormal_vision | 1.04400421 |
| 90 | MP0008057_abnormal_DNA_replication | 0.99471990 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.98349255 |
| 92 | MP0003045_fibrosis | 0.97486780 |
| 93 | MP0002938_white_spotting | 0.94579480 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.93299458 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.93226496 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.92874934 |
| 97 | MP0005253_abnormal_eye_physiology | 0.91777117 |
| 98 | MP0002069_abnormal_eating/drinking_beha | 0.90198575 |
| 99 | MP0004085_abnormal_heartbeat | 0.89941793 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.87798975 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.87450220 |
| 102 | MP0001664_abnormal_digestion | 0.87186443 |
| 103 | MP0004130_abnormal_muscle_cell | 0.86786468 |
| 104 | MP0001905_abnormal_dopamine_level | 0.85814874 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.85025127 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.84281347 |
| 107 | MP0005647_abnormal_sex_gland | 0.84242032 |
| 108 | MP0003959_abnormal_lean_body | 0.83906020 |
| 109 | MP0003632_abnormal_nervous_system | 0.83814943 |
| 110 | MP0005195_abnormal_posterior_eye | 0.83003706 |
| 111 | MP0004381_abnormal_hair_follicle | 0.82672603 |
| 112 | MP0000026_abnormal_inner_ear | 0.81976859 |
| 113 | MP0003890_abnormal_embryonic-extraembry | 0.81976322 |
| 114 | MP0002095_abnormal_skin_pigmentation | 0.81404199 |
| 115 | MP0005670_abnormal_white_adipose | 0.81254499 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.79775468 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.79396188 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.79027610 |
| 119 | MP0005389_reproductive_system_phenotype | 0.78890055 |
| 120 | MP0004484_altered_response_of | 0.78027077 |
| 121 | MP0005448_abnormal_energy_balance | 0.77590268 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.77455771 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.77324633 |
| 124 | MP0002234_abnormal_pharynx_morphology | 0.76547792 |
| 125 | MP0002752_abnormal_somatic_nervous | 0.75766397 |
| 126 | MP0004742_abnormal_vestibular_system | 0.75630198 |
| 127 | MP0001944_abnormal_pancreas_morphology | 0.75228887 |
| 128 | MP0005187_abnormal_penis_morphology | 0.73988007 |
| 129 | MP0005535_abnormal_body_temperature | 0.73843678 |
| 130 | MP0005379_endocrine/exocrine_gland_phen | 0.70201420 |
| 131 | MP0000747_muscle_weakness | 0.69673314 |
| 132 | MP0001188_hyperpigmentation | 0.69137349 |
| 133 | MP0001177_atelectasis | 0.68915115 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.67572597 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.66492713 |
| 136 | MP0008874_decreased_physiological_sensi | 0.63269435 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.62823011 |
| 138 | MP0008872_abnormal_physiological_respon | 0.60288199 |
| 139 | MP0003075_altered_response_to | 0.60090194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.59631082 |
| 2 | Myokymia (HP:0002411) | 5.22644547 |
| 3 | Visual hallucinations (HP:0002367) | 4.60205568 |
| 4 | Focal seizures (HP:0007359) | 4.49801094 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.99933487 |
| 6 | Pancreatic cysts (HP:0001737) | 3.85309298 |
| 7 | Action tremor (HP:0002345) | 3.82071435 |
| 8 | Clumsiness (HP:0002312) | 3.81401810 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.68255906 |
| 10 | True hermaphroditism (HP:0010459) | 3.59723008 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.59342581 |
| 12 | Papilledema (HP:0001085) | 3.45608080 |
| 13 | Protruding tongue (HP:0010808) | 3.41261140 |
| 14 | Attenuation of retinal blood vessels (HP:0007843) | 3.37870809 |
| 15 | Absence seizures (HP:0002121) | 3.32515510 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.30468865 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.25041351 |
| 18 | Febrile seizures (HP:0002373) | 3.24784353 |
| 19 | Depression (HP:0000716) | 3.20808356 |
| 20 | Ankle clonus (HP:0011448) | 3.15650579 |
| 21 | Truncal ataxia (HP:0002078) | 3.13408100 |
| 22 | Atonic seizures (HP:0010819) | 3.06654803 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.01874961 |
| 24 | Macroorchidism (HP:0000053) | 2.94388594 |
| 25 | Dialeptic seizures (HP:0011146) | 2.93819371 |
| 26 | Intention tremor (HP:0002080) | 2.93120936 |
| 27 | Poor eye contact (HP:0000817) | 2.92431827 |
| 28 | Broad-based gait (HP:0002136) | 2.91466511 |
| 29 | Chronic hepatic failure (HP:0100626) | 2.89835697 |
| 30 | Abnormality of the renal cortex (HP:0011035) | 2.88553144 |
| 31 | Dysmetria (HP:0001310) | 2.88547872 |
| 32 | Megalencephaly (HP:0001355) | 2.87281229 |
| 33 | Postural instability (HP:0002172) | 2.85380554 |
| 34 | Cystic liver disease (HP:0006706) | 2.82646613 |
| 35 | Proximal tubulopathy (HP:0000114) | 2.81097594 |
| 36 | Scanning speech (HP:0002168) | 2.80245718 |
| 37 | Abnormal social behavior (HP:0012433) | 2.76076906 |
| 38 | Impaired social interactions (HP:0000735) | 2.76076906 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 2.76061891 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73661298 |
| 41 | Excessive salivation (HP:0003781) | 2.72154831 |
| 42 | Drooling (HP:0002307) | 2.72154831 |
| 43 | Anxiety (HP:0000739) | 2.71374041 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.70986208 |
| 45 | Congenital sensorineural hearing impairment (HP:0008527) | 2.69806543 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.63586673 |
| 47 | Hyperkalemia (HP:0002153) | 2.62457381 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.61270555 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.61270555 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.60461246 |
| 51 | Impaired smooth pursuit (HP:0007772) | 2.59576011 |
| 52 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.59289815 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.55716690 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.55526586 |
| 55 | Pendular nystagmus (HP:0012043) | 2.54837619 |
| 56 | Polydipsia (HP:0001959) | 2.54508075 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.54508075 |
| 58 | Type II lissencephaly (HP:0007260) | 2.54105139 |
| 59 | Fair hair (HP:0002286) | 2.50122722 |
| 60 | Genetic anticipation (HP:0003743) | 2.50042922 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.49795549 |
| 62 | Decreased circulating renin level (HP:0003351) | 2.47677894 |
| 63 | Hemiplegia (HP:0002301) | 2.47161680 |
| 64 | Chorioretinal atrophy (HP:0000533) | 2.47003918 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.46141130 |
| 66 | Spastic gait (HP:0002064) | 2.45390111 |
| 67 | Hyperventilation (HP:0002883) | 2.44618616 |
| 68 | Keratoconus (HP:0000563) | 2.44550821 |
| 69 | Increased corneal curvature (HP:0100692) | 2.44550821 |
| 70 | Central scotoma (HP:0000603) | 2.38734735 |
| 71 | Agitation (HP:0000713) | 2.37146668 |
| 72 | Ankyloglossia (HP:0010296) | 2.35723032 |
| 73 | Hemiparesis (HP:0001269) | 2.35322187 |
| 74 | Furrowed tongue (HP:0000221) | 2.35108573 |
| 75 | Decreased central vision (HP:0007663) | 2.35038913 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34265935 |
| 77 | Sclerocornea (HP:0000647) | 2.33009777 |
| 78 | Nephronophthisis (HP:0000090) | 2.32765871 |
| 79 | Abnormal eating behavior (HP:0100738) | 2.31896357 |
| 80 | Oligodactyly (hands) (HP:0001180) | 2.31405070 |
| 81 | Urinary urgency (HP:0000012) | 2.28886511 |
| 82 | Severe visual impairment (HP:0001141) | 2.28273121 |
| 83 | Torticollis (HP:0000473) | 2.28134904 |
| 84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27136225 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 2.27136225 |
| 86 | Hyperalaninemia (HP:0003348) | 2.27136225 |
| 87 | Pheochromocytoma (HP:0002666) | 2.27130866 |
| 88 | Abnormality of the renal medulla (HP:0100957) | 2.25364730 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.22952242 |
| 90 | Bradykinesia (HP:0002067) | 2.22116285 |
| 91 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.21750818 |
| 92 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20578564 |
| 93 | Birth length less than 3rd percentile (HP:0003561) | 2.20341996 |
| 94 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.20126922 |
| 95 | Mutism (HP:0002300) | 2.19069736 |
| 96 | Hypoplastic ischia (HP:0003175) | 2.17584098 |
| 97 | Inability to walk (HP:0002540) | 2.17355261 |
| 98 | Abnormality of the ischium (HP:0003174) | 2.16383651 |
| 99 | Stereotypic behavior (HP:0000733) | 2.16233731 |
| 100 | Dysmetric saccades (HP:0000641) | 2.15543607 |
| 101 | Insomnia (HP:0100785) | 2.15458502 |
| 102 | Lower limb muscle weakness (HP:0007340) | 2.15203215 |
| 103 | Congenital hepatic fibrosis (HP:0002612) | 2.12981206 |
| 104 | Neoplasm of the heart (HP:0100544) | 2.10375649 |
| 105 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.09558897 |
| 106 | Abnormality of macular pigmentation (HP:0008002) | 2.09152713 |
| 107 | Insidious onset (HP:0003587) | 2.08635517 |
| 108 | Termporal pattern (HP:0011008) | 2.08635517 |
| 109 | Prolonged QT interval (HP:0001657) | 2.07525669 |
| 110 | Tubular atrophy (HP:0000092) | 2.06810840 |
| 111 | Acute lymphatic leukemia (HP:0006721) | 2.06407837 |
| 112 | Focal dystonia (HP:0004373) | 2.06268326 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05817590 |
| 114 | Large for gestational age (HP:0001520) | 2.05791815 |
| 115 | Postaxial foot polydactyly (HP:0001830) | 2.05076488 |
| 116 | Abnormal EKG (HP:0003115) | 2.03140590 |
| 117 | Blue irides (HP:0000635) | 2.01958277 |
| 118 | Clonus (HP:0002169) | 2.01830967 |
| 119 | Renal cortical cysts (HP:0000803) | 2.00777888 |
| 120 | Widely spaced teeth (HP:0000687) | 1.99248076 |
| 121 | Pointed chin (HP:0000307) | 1.98922133 |
| 122 | Abolished electroretinogram (ERG) (HP:0000550) | 1.98796143 |
| 123 | Progressive inability to walk (HP:0002505) | 1.96352519 |
| 124 | Amblyopia (HP:0000646) | 1.95791297 |
| 125 | Menstrual irregularities (HP:0000858) | 1.94727151 |
| 126 | Abnormality of the lower motor neuron (HP:0002366) | 1.93977274 |
| 127 | Resting tremor (HP:0002322) | 1.93038706 |
| 128 | Abnormality of binocular vision (HP:0011514) | 1.90289243 |
| 129 | Diplopia (HP:0000651) | 1.90289243 |
| 130 | Retinal dysplasia (HP:0007973) | 1.89565001 |
| 131 | Impaired vibratory sensation (HP:0002495) | 1.88365048 |
| 132 | Abnormality of the corticospinal tract (HP:0002492) | 1.88187574 |
| 133 | Aplasia involving bones of the extremities (HP:0009825) | 1.88013845 |
| 134 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.88013845 |
| 135 | Aplasia of the phalanges of the hand (HP:0009802) | 1.88013845 |
| 136 | Bundle branch block (HP:0011710) | 1.87857640 |
| 137 | Gait ataxia (HP:0002066) | 1.84094333 |
| 138 | Craniofacial dystonia (HP:0012179) | 1.83944901 |
| 139 | Anencephaly (HP:0002323) | 1.82911972 |
| 140 | Occipital encephalocele (HP:0002085) | 1.82131058 |
| 141 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82042863 |
| 142 | Depressed nasal tip (HP:0000437) | 1.80820706 |
| 143 | Hypoplasia of the fovea (HP:0007750) | 1.80357204 |
| 144 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.80357204 |
| 145 | Status epilepticus (HP:0002133) | 1.80109185 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.79427466 |
| 147 | Open mouth (HP:0000194) | 1.79313264 |
| 148 | Patellar aplasia (HP:0006443) | 1.79145620 |
| 149 | Short foot (HP:0001773) | 1.78589644 |
| 150 | Absent speech (HP:0001344) | 1.77774037 |
| 151 | Abnormality of oral frenula (HP:0000190) | 1.77059301 |
| 152 | Hypoplasia of the iris (HP:0007676) | 1.76978373 |
| 153 | Lower limb amyotrophy (HP:0007210) | 1.76779154 |
| 154 | Generalized hypopigmentation of hair (HP:0011358) | 1.76357862 |
| 155 | Aqueductal stenosis (HP:0002410) | 1.75571221 |
| 156 | Small hand (HP:0200055) | 1.75201442 |
| 157 | Ventricular fibrillation (HP:0001663) | 1.74178064 |
| 158 | Medial flaring of the eyebrow (HP:0010747) | 1.73731988 |
| 159 | Gait imbalance (HP:0002141) | 1.73299701 |
| 160 | Congenital stationary night blindness (HP:0007642) | 1.72795143 |
| 161 | Concave nail (HP:0001598) | 1.69992676 |
| 162 | Postural tremor (HP:0002174) | 1.69932502 |
| 163 | Abnormality of potassium homeostasis (HP:0011042) | 1.67906909 |
| 164 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.67500884 |
| 165 | Obsessive-compulsive behavior (HP:0000722) | 1.66990062 |
| 166 | Spinal canal stenosis (HP:0003416) | 1.66285334 |
| 167 | Generalized myoclonic seizures (HP:0002123) | 1.65983328 |
| 168 | Intellectual disability, progressive (HP:0006887) | 1.65964017 |
| 169 | Hypoventilation (HP:0002791) | 1.65879742 |
| 170 | Palpebral edema (HP:0100540) | 1.63150597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.13298912 |
| 2 | BMPR1B | 3.24077665 |
| 3 | MAP3K9 | 3.23682665 |
| 4 | EPHA4 | 3.11921949 |
| 5 | NTRK1 | 3.02583614 |
| 6 | MARK1 | 3.00917295 |
| 7 | NTRK2 | 2.93961812 |
| 8 | LATS1 | 2.74172731 |
| 9 | PRKD3 | 2.63941092 |
| 10 | ACVR1B | 2.61045405 |
| 11 | MAP3K4 | 2.52014119 |
| 12 | KSR1 | 2.37004190 |
| 13 | MUSK | 2.33784128 |
| 14 | ADRBK2 | 2.30217546 |
| 15 | MINK1 | 2.29952759 |
| 16 | PAK6 | 2.26583182 |
| 17 | DAPK2 | 2.10633301 |
| 18 | TNIK | 2.05446554 |
| 19 | MAP2K7 | 1.85075495 |
| 20 | KSR2 | 1.82488347 |
| 21 | SIK3 | 1.67481523 |
| 22 | CAMKK1 | 1.65389625 |
| 23 | CDK5 | 1.52167503 |
| 24 | STK38L | 1.50607200 |
| 25 | GRK1 | 1.48078383 |
| 26 | MAP3K2 | 1.41939581 |
| 27 | PHKG2 | 1.38189771 |
| 28 | PHKG1 | 1.38189771 |
| 29 | FGFR2 | 1.36863382 |
| 30 | CAMKK2 | 1.31437595 |
| 31 | MAP2K4 | 1.31369963 |
| 32 | PTK2B | 1.31238688 |
| 33 | CDK12 | 1.28028396 |
| 34 | UHMK1 | 1.26841801 |
| 35 | INSRR | 1.25070047 |
| 36 | PRKCH | 1.24931237 |
| 37 | PRPF4B | 1.18912888 |
| 38 | ADRBK1 | 1.16197649 |
| 39 | STK38 | 1.13655910 |
| 40 | AKT3 | 1.12222566 |
| 41 | TAOK1 | 1.11464067 |
| 42 | CAMK1G | 1.08867689 |
| 43 | MAPK13 | 1.08688815 |
| 44 | STK39 | 1.06891126 |
| 45 | WNK4 | 1.04464906 |
| 46 | TYRO3 | 1.03932234 |
| 47 | PIK3CA | 1.03837911 |
| 48 | SCYL2 | 1.03217308 |
| 49 | SGK223 | 1.03019221 |
| 50 | SGK494 | 1.03019221 |
| 51 | MARK2 | 1.02552397 |
| 52 | PAK3 | 1.01239648 |
| 53 | CDK19 | 0.99388778 |
| 54 | FES | 0.98213737 |
| 55 | SIK1 | 0.97986745 |
| 56 | RET | 0.97928823 |
| 57 | SIK2 | 0.95255955 |
| 58 | LMTK2 | 0.94968488 |
| 59 | TAOK3 | 0.93812487 |
| 60 | CDC42BPA | 0.92285346 |
| 61 | STK11 | 0.91818743 |
| 62 | ZAK | 0.90614057 |
| 63 | MAP2K1 | 0.89477315 |
| 64 | MKNK2 | 0.89441675 |
| 65 | MAPKAPK3 | 0.88822062 |
| 66 | NUAK1 | 0.86732897 |
| 67 | CASK | 0.86441869 |
| 68 | TGFBR1 | 0.86301361 |
| 69 | BCR | 0.86104880 |
| 70 | PRKCG | 0.85917116 |
| 71 | DAPK1 | 0.85827280 |
| 72 | CAMK1 | 0.85741618 |
| 73 | NEK9 | 0.85494457 |
| 74 | CSNK1A1L | 0.84536457 |
| 75 | CDK18 | 0.84326806 |
| 76 | MAP3K13 | 0.84067618 |
| 77 | CAMK2A | 0.82803237 |
| 78 | SGK2 | 0.82441887 |
| 79 | SGK3 | 0.82072701 |
| 80 | WEE1 | 0.81900972 |
| 81 | MAP3K7 | 0.78893180 |
| 82 | HIPK2 | 0.78306117 |
| 83 | GRK5 | 0.77265971 |
| 84 | FRK | 0.76489834 |
| 85 | NLK | 0.76096029 |
| 86 | GRK7 | 0.75189435 |
| 87 | CDK15 | 0.75043947 |
| 88 | MAP4K2 | 0.74009762 |
| 89 | SGK1 | 0.73608299 |
| 90 | PDGFRA | 0.73330428 |
| 91 | MELK | 0.72930230 |
| 92 | DMPK | 0.72822705 |
| 93 | MAP3K1 | 0.72612802 |
| 94 | PDGFRB | 0.71635936 |
| 95 | STK3 | 0.71277299 |
| 96 | CHEK2 | 0.70912426 |
| 97 | CDK14 | 0.70603421 |
| 98 | TRPM7 | 0.70444844 |
| 99 | CAMK2B | 0.69039333 |
| 100 | MAP3K12 | 0.68812258 |
| 101 | WNK1 | 0.67567914 |
| 102 | TLK1 | 0.67238779 |
| 103 | PNCK | 0.66190669 |
| 104 | CSNK1G2 | 0.65260000 |
| 105 | RIPK1 | 0.63880907 |
| 106 | NEK6 | 0.63809716 |
| 107 | MAPKAPK5 | 0.63685026 |
| 108 | OXSR1 | 0.62810674 |
| 109 | CDK11A | 0.62220856 |
| 110 | TAF1 | 0.61937395 |
| 111 | WNK3 | 0.60278130 |
| 112 | ALK | 0.59712506 |
| 113 | TNK2 | 0.59116616 |
| 114 | IRAK1 | 0.58771525 |
| 115 | RIPK4 | 0.58468513 |
| 116 | PRKD2 | 0.58357084 |
| 117 | PDK1 | 0.58299588 |
| 118 | PINK1 | 0.57804730 |
| 119 | RPS6KA3 | 0.57733423 |
| 120 | FYN | 0.55968729 |
| 121 | MAP2K6 | 0.54413872 |
| 122 | ICK | 0.53754988 |
| 123 | MAPK15 | 0.53622357 |
| 124 | CAMK2D | 0.53063493 |
| 125 | DYRK1A | 0.52994257 |
| 126 | PDPK1 | 0.52438304 |
| 127 | CAMK1D | 0.51728876 |
| 128 | RAF1 | 0.50276181 |
| 129 | MAPK10 | 0.50040536 |
| 130 | PRKCZ | 0.49517746 |
| 131 | PLK2 | 0.48990895 |
| 132 | PRKCE | 0.48155269 |
| 133 | LATS2 | 0.47162994 |
| 134 | TRIB3 | 0.46442999 |
| 135 | FER | 0.45919108 |
| 136 | ERBB2 | 0.45418756 |
| 137 | PRKAA2 | 0.44466382 |
| 138 | PKN1 | 0.44018876 |
| 139 | CAMK4 | 0.43983527 |
| 140 | CSNK1D | 0.43559281 |
| 141 | MAP2K2 | 0.43277099 |
| 142 | PRKAA1 | 0.42908160 |
| 143 | CSNK1G1 | 0.42867877 |
| 144 | RPS6KA6 | 0.38212212 |
| 145 | PRKACB | 0.35567137 |
| 146 | OBSCN | 0.35184737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.02348219 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67771900 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.62686094 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49886338 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.41200461 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34013915 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.33484483 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32083003 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31348147 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22291883 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11266115 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10459046 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.98229970 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92629325 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82538611 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82255709 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73706840 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72024379 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.70651749 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70407619 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.69644621 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.67582861 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66713166 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.64885727 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64262809 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.50688998 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50209551 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48328640 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.46684183 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43595015 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.43221126 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.42243144 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42195046 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40219879 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37215368 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33046244 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31365154 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.27755728 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.26878068 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25860070 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25295159 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22922780 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.21661082 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16808393 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15286121 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13067318 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12019923 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11573212 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.10795605 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.06474763 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04767478 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04740803 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03733877 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02488023 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01676846 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01410831 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.01392704 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00994112 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99912913 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97394633 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96655159 |
| 62 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95567732 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.94873111 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94238959 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93694324 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93120319 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91238842 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88609143 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86375895 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85940649 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79620976 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78965201 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78488885 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76753245 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76654409 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75618355 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75312915 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74875241 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.74381547 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73887248 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73793036 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71913323 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71614150 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69901889 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67188597 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66756857 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66743007 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66623326 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66298557 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66143226 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63985933 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63980276 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62262351 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62261313 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61680864 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60494415 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59996310 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59209926 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.59014131 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58697829 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58369958 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58352992 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.57222039 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56952791 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56535708 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53341819 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52727704 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51851148 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51532011 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.51123418 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49108322 |
| 112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49037041 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48212375 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48192869 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47543850 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46689082 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46281178 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46107349 |
| 119 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45910858 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45613171 |
| 121 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45530795 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45273486 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.45185978 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.44282711 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43852018 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42775394 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42243065 |
| 128 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42122485 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38641962 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.38192185 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.37714944 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37128020 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33672896 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33421612 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33333244 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33109246 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32953955 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32923313 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31300041 |

